138 related articles for article (PubMed ID: 25750858)
1. Image-guided Interstitial Photodynamic Therapy for Squamous Cell Carcinomas: Preclinical investigation.
Sajisevi M; Rigual NR; Bellnier DA; Seshadri M
J Oral Maxillofac Surg Med Pathol; 2015 Mar; 27(2):159-165. PubMed ID: 25750858
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a in photodynamic therapy of human esophageal squamous cancer cells.
Wu D; Liu Z; Fu Y; Zhang Y; Tang N; Wang Q; Tao L
Oncol Lett; 2013 Oct; 6(4):1111-1119. PubMed ID: 24137473
[TBL] [Abstract][Full Text] [Related]
3. Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
Furukawa K; Yamamoto H; Crean DH; Kato H; Mang TS
Lasers Surg Med; 1996; 18(2):157-66. PubMed ID: 8833284
[TBL] [Abstract][Full Text] [Related]
4. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.
Lobel J; MacDonald IJ; Ciesielski MJ; Barone T; Potter WR; Pollina J; Plunkett RJ; Fenstermaker RA; Dougherty TJ
Lasers Surg Med; 2001; 29(5):397-405. PubMed ID: 11891727
[TBL] [Abstract][Full Text] [Related]
5. MRI assessment of treatment delivery for interstitial photodynamic therapy of high-grade glioma in a preclinical model.
Leroy HA; Vermandel M; Leroux B; Duhamel A; Lejeune JP; Mordon S; Reyns N
Lasers Surg Med; 2018 Jul; 50(5):460-468. PubMed ID: 29023876
[TBL] [Abstract][Full Text] [Related]
6. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
[TBL] [Abstract][Full Text] [Related]
7. Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma.
Toussaint M; Pinel S; Auger F; Durieux N; Thomassin M; Thomas E; Moussaron A; Meng D; Plénat F; Amouroux M; Bastogne T; Frochot C; Tillement O; Lux F; Barberi-Heyob M
Theranostics; 2017; 7(2):436-451. PubMed ID: 28255341
[TBL] [Abstract][Full Text] [Related]
8. Strategies of airway management for head and neck photo-dynamic therapy.
Story W; Sultan AA; Bottini G; Vaz F; Lee G; Hopper C
Lasers Surg Med; 2013 Aug; 45(6):370-6. PubMed ID: 23775429
[TBL] [Abstract][Full Text] [Related]
9. Mesoscopic fluorescence tomography of a photosensitizer (HPPH) 3D biodistribution in skin cancer.
Ozturk MS; Rohrbach D; Sunar U; Intes X
Acad Radiol; 2014 Feb; 21(2):271-80. PubMed ID: 24439340
[TBL] [Abstract][Full Text] [Related]
10. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
[TBL] [Abstract][Full Text] [Related]
12. Detection of Treatment Success after Photodynamic Therapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Schreurs TJL; Jacobs I; Nicolay K; Prompers JJ; Strijkers GJ
Theranostics; 2017; 7(19):4643-4657. PubMed ID: 29187893
[TBL] [Abstract][Full Text] [Related]
13. Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
Werning JW; Stepnick DW; Jafri A; Megerian CA; Antunez AR; Zaidi SI
Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):783-9. PubMed ID: 7598858
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Multi-Parametric Magnetic Resonance Imaging of Tumor Response to Photodynamic Therapy.
Schreurs TJ; Hectors SJ; Jacobs I; Grüll H; Nicolay K; Strijkers GJ
PLoS One; 2016; 11(11):e0165759. PubMed ID: 27820832
[TBL] [Abstract][Full Text] [Related]
15. Explicit dosimetry for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a-mediated photodynamic therapy: macroscopic singlet oxygen modeling.
Penjweini R; Liu B; Kim MM; Zhu TC
J Biomed Opt; 2015; 20(12):128003. PubMed ID: 26720883
[TBL] [Abstract][Full Text] [Related]
16. A Phase I Study of Light Dose for Photodynamic Therapy Using 2-[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a for the Treatment of Non-Small Cell Carcinoma In Situ or Non-Small Cell Microinvasive Bronchogenic Carcinoma: A Dose Ranging Study.
Dhillon SS; Demmy TL; Yendamuri S; Loewen G; Nwogu C; Cooper M; Henderson BW
J Thorac Oncol; 2016 Feb; 11(2):234-41. PubMed ID: 26718878
[TBL] [Abstract][Full Text] [Related]
17. Fractionated versus standard continuous light delivery in interstitial photodynamic therapy of dunning prostate carcinomas.
Xiao Z; Halls S; Dickey D; Tulip J; Moore RB
Clin Cancer Res; 2007 Dec; 13(24):7496-505. PubMed ID: 18094434
[TBL] [Abstract][Full Text] [Related]
18. MR imaging-guided interstitial photodynamic laser therapy for advanced head and neck tumors.
Jäger HR; Taylor MN; Theodossy T; Hopper C
AJNR Am J Neuroradiol; 2005 May; 26(5):1193-200. PubMed ID: 15891183
[TBL] [Abstract][Full Text] [Related]
19. Gap junction enhances phototoxicity of photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH).
Liu Z; Wang Q; Fan L; Wu DP; Zhang Y; Liu L; Tao L
Lasers Surg Med; 2015 Jan; 47(1):68-76. PubMed ID: 25483871
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the clinical, histological, and biological characteristics of squamous cell carcinomas in areas previously treated with photodynamic therapy.
Gracia Cazaña T; Salazar N; Vera-Álvarez J; González S; Juarranz A; Gilaberte Y
Eur J Dermatol; 2017 Dec; 27(6):627-634. PubMed ID: 29141833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]